Expansion of insulin price caps and calls for regulation in the US
- 1North Dakota has implemented a measure setting a $25 monthly cap on insulin costs for patients.
- 2As the average annual out-of-pocket cost for private insurance holders reached $470 in 2018, movements are emerging to protect an estimated 40 million Americans with diabetes.
- 3Seven out of 10 US adults responded that government regulation to limit prescription drug prices is insufficient.
So what's the key point?
North Dakota has limited insulin costs to $25 per month. Efforts are underway to protect people living with diabetes.
Source Fortune · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.